Nucl Med Mol Imaging.  2006 Oct;40(5):275-278.

Discrepancy of Bone Metastases between F-18 FDG PET/CT and Bone Scan in a Patient with Prostate Cancer

Affiliations
  • 1Department of Nuclear Medicine, Inha University College of Medicine, Incheon, Korea. iyhyun@inha.ac.kr
  • 2Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea.
  • 3Department of Radiology, Inha University College of Medicine, Incheon, Korea.

Abstract

We report the case of a 73-year-old man who had prostate cancer with bone metastases. Tc-99m HDP Whole body bone scan revealed multiple areas of increased bony uptake consistent with widespread bone metastases. F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) demonstrated mild F-18 FDG uptake in the lymph nodes of neck, abdomen, and pelvis. However, abnormal F-18 FDG uptake was not seen in the skeletal system. Biopsy and immunohistochemical stains of left supraclavicular mass showed metastatic prostate adenocarcinoma. Currently, there are a few reported cases of F-18 FDG PET/CT evaluation of bone metastases in prostate cancer. We discuss the discrepancy between F-18 FDG PET/CT and bone scan in the detection of osseous metastases of prostate cancer.

Keyword

osseous metastases; bone scan; F-18 FDG PET/CT; prostate cancer

MeSH Terms

Abdomen
Adenocarcinoma
Aged
Biopsy
Coloring Agents
Electrons
Humans
Lymph Nodes
Neck
Neoplasm Metastasis*
Pelvis
Positron-Emission Tomography and Computed Tomography*
Prostate*
Prostatic Neoplasms*
Coloring Agents
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr